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Abstract
Background: While most nucleic acids are intracellular, trace amounts of deoxyribonucleic acid (DNA) and ribonucleic acid
(RNA), including micro RNAs, can also be found in peripheral blood. Many studies have suggested the potential utility of
these circulating nucleic acids in prenatal diagnosis, early cancer detection, and the diagnosis of infectious diseases.
However, DNA circulating in blood is usually present at very low concentrations (ng/ml), and is in the form of relatively small
fragments (,1,000 bp), making its isolation challenging.
Methods: Here we report an improved method for the isolation of small DNA fragments from serum using selective
precipitation by quaternary ammonium compaction agents. A 151 bp fragment of double-stranded DNA from the
Escherichia coli bacteriophage lambda served as the model DNA in our experiments. DNA was serially diluted in serum until
undetectable by conventional polymerase chain reaction (PCR), before being enriched by compaction precipitation.
Results: Starting with concentrations two to three orders of magnitude lower than the PCR-detectable level (0.01 ng/ml),
we were able to enrich the DNA to a detectable level using a novel compaction precipitation protocol. The isolated DNA
product after compaction precipitation was largely free of serum contaminants and was suitable for downstream
applications.
Conclusions: Using compaction precipitation, we were able to isolate and concentrate small DNA from serum, and increase
the sensitivity of detection by more than four orders of magnitude. We were able to recover and detect very low levels
(0.01 ng/ml) of a small DNA fragment in serum. In addition to being very sensitive, the method is fast, simple, inexpensive,
and avoids the use of toxic chemicals.
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Introduction
It is well known that trace amounts of cell-free, circulating
deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and micro
RNA are present in human blood [1]. The prospect of obtaining
prognostic or diagnostic information from these nucleic acids is
highly attractive, and previous studies have already established
that, for instance, the circulating concentrations of specific
nucleotide sequences are significantly higher in prostate, breast
and lung cancer patients [2,3,4]. There also is extensive work on
the value of circulating, trace fetal DNA in the mother’s blood,
both as a predictive and as a diagnostic marker [5,6]. Current
methods of isolating cell-free circulating DNA and RNA suffer
from low sensitivity and often use toxic chemicals such as phenol
and chloroform [7,8,9,10,11]. Here we report a new, highly-
sensitive, simple and inexpensive method to selectively isolate and
concentrate small DNA from serum using compaction agents.
Compaction agents are small, cationic molecules which interact
selectively with the phosphate backbone and groove of nucleic acid
molecules. This interaction can change the conformation of
nucleic acids into a compact form which can precipitate out of
solution [12]. In the past, compaction agents have been used to
selectively precipitate DNA from complex mixtures
[13,14,15,16,17].
Materials and Methods
Trace DNA Analyte
To simulate small circulating nucleic acids in blood, we spiked
a 151 bp lambda genomic polymerase chain reaction (PCR)
amplicon at different concentrations into human serum (Gulf
Coast Regional Blood Center, Houston, TX). The fragment was
chosen so that the necessary primers would have no significant
homology to any human sequences, and was prepared by PCR
amplification using total lambda genomic DNA (Affymetrix,
Cleveland, OH) as the template. The primers used were: F1, 59-
GGCTTCGGTCCCTTCTGT-39, and R1, 59-CTCTTCCA-
GAAACGACTCCAG-39 (IDT, Coralville, IA).
In addition, beta-globin-encoding DNA, normally found at low
levels in human plasma [18], was used to test the effectiveness of
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various methods of isolating circulating DNA. For its amplification
we used the forward primer 59-ACACAACTGTGTTCAC-
TAGC-39 and the reverse primer 59-CAACTTCATCCACGTT-
CACC-39 (IDT, Coralville, IA) [18].
Compaction Precipitation
Quatroquat (QQ SBSTM 8915, Sachem, Austin, TX) and
spermine-HCl (S1141, Sigma, St. Louis, MO) were used as
compaction agents. Various protocols were tested to determine the
most effective and efficient method as discussed below. In the final
recommended protocol, human serum samples (1 ml) are diluted
with nuclease-free water (1.5 ml, OmniPur, EMD Chemicals,
Gibbstown, NJ) and heated at 95uC for 15 min to non-specifically
precipitate serum proteins. The sample is then vortexed 5 sec,
then centrifuged at 16,0006g for 15 min to remove the protein
precipitate. The supernatant is recovered and compaction agent is
added to a concentration of 2.5 mM. After 15 min incubation on
an end-to-end rotator, the samples are again centrifuged at
16,0006g for 15 min. The supernatant is discarded and the DNA
pellet is washed with 100 ml Wash Buffer (50% isopropanol,
300 mM NaCl, 10 mM MgCl2) and 100 ml 75% ethanol, with
centrifugation at 16,0006g for 10 min after each wash. The pellet
is then dried in a SpeedVac, before finally being dissolved in 20 ml
10 mM Tris-HCl, pH 7.4.
Real-time PCR Detection
Real-time PCR for the detection and measurement of DNA was
conducted using the Brilliant II SYBR GreenH QPCR reagent
(Agilent, Santa Clara, CA) in an Mx3000P QPCR system
(Agilent). After compaction precipitation, the samples were
subjected to real-time PCR without further purification. The
original lambda DNA served as a positive control. Primers were
the same primers used in preparing the template. All PCRs were
set up with 1 ml of sample in 25 ml total volume. PCR conditions
were: 95uC for 10 min followed by 35 cycles of 45 s denaturation
at 95uC, 1 min annealing at 55uC, followed by 30 s extension at
72uC.
Results and Discussion
We first investigated the effect of varying the concentration of
the compaction agent concentration. Ten ng/ml of a 151 bp
lambda model DNA amplicon was serially diluted in serum. The
samples were diluted with 1.5 volumes of water and heated to
95uC for 15 min. Denatured aggregated proteins were then
removed by centrifugation. The supernatants after centrifugation
were precipitated with compaction agents at concentrations
between 0 and 32 mM. After analysis of the spiked samples in
the various reactions by real-time PCR, we identified an optimal
concentration range for each of our compaction agents of 1–
5 mM. As shown in Figure 1.A, higher concentrations of spermine
noticeably reduced the sensitivity of the PCR. The results for
quatroquat showed the same effect (Figure 1.B). It is known that at
low and optimal concentration compaction agents interact with
the negatively charged DNA backbone to form intermolecular
aggregates [14].
Variation of the incubation time of the sample with the
compaction agent showed that it had no significant effect on the
sensitivity of the subsequent PCR. Serum samples were spiked
with 10 ng/ml target DNA, diluted with 1.5 volumes of water,
heat-treated as described above, and then divided into two sets,
one for each compaction agent. Each set was then subdivided into
seven reactions which were treated with 2 mM compaction agent
for incubation times ranging from 1 min to 15 hr. Analysis by
real-time PCR showed no benefit of prolonged incubation times.
In fact, an incubation time of 1 min gave virtually the same level of
sensitivity (Ct = 6.68 for spermine, and 6.13 for quatroquat) as
a 15 hr incubation (Ct = 6.69 for spermine, and 6.35 for
quatroquat) for both compaction agents. We believe that the brief
incubation time is a significant advantage of the method; the
protocol is simple and can be completed in less than 1.5 hours.
Figure 1. Effect of compaction agent concentration on DNA precipitation. Three sets of human serum samples containing 10, 1, and 0.1 ng/
ml of lambda DNA were heat treated and compaction precipitated with various concentrations of spermine and quatroquat.
doi:10.1371/journal.pone.0051863.g001
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To examine the need for the heat treatment in the protocol,
serum samples were aliquoted into two treatment sets: heat treated
and not heat treated. Without heat treatment samples subjected to
one round of compaction precipitation were detected 3 to 5 cycles
later than samples with heat treatment (Table 1). The results
showed that heat treatment improved the sensitivity of the real-
time PCR. We attribute these results to the removal of inhibitory
serum components such as immunoglobulin G and lactoferrin
[19,20] from the PCR by heat. Our real-time PCR results showed
that the heat treatment effectively removed these inhibitors,
improving the limit of detection by at least an order of magnitude.
In optimizing the procedure, we tested a number of variations of
the main protocol. As outlined, the original protocol involved heat
treatment followed by one round of compaction precipitation. The
results were significantly better than heat treatment alone (Table 1).
With heat treatment, two rounds of compaction precipitation with
either spermine or quatroquat did not improve the outcome
(Table 1). Without heat treatment, two rounds of compaction
precipitation gave virtually the same results as heat treatment with
one round of compaction precipitation. Thus, when heating is not
desirable, a second round of compaction precipitation can be
substituted.
The possible effect of inter-specimen variation on the compac-
tion precipitation method was examined using 20 distinct serum
samples. The samples were divided into four sets, one for each
spiked DNA concentration, ranging from 0.01–10 ng/ml. The
samples were subjected to purification by compaction precipitation
with spermine as described above, followed by real-time PCR.
The real-time PCR analysis after compaction precipitation showed
no significant variation in DNA recovery among the donors at any
of the four DNA concentrations. The average (6SD) Ct values
were 6.660.2, 10.360.7, 15.860.9, and 17.660.4 for spiked
DNA concentrations of 10, 1, 0.1, and 0.01 ng/ml, respectively.
Similar results were obtained with quatroquat, the average (6SD)
Ct values were 6.660.3 for 10 ng/ml, 10.360.9 for 1 ng/ml,
1461 for 0.1 ng/ml, and 17.160.5 for 0.01 ng/ml. These results
demonstrated the high reproducibility (average coefficient of
variation= 5.4%) of the compaction precipitation method across
donors.
Compaction precipitation also was compared with the well-
developed commercial QIAamp Circulating Nucleic Acid Kit.
Pooled serum was spiked with DNA in various concentrations and
subjected to DNA purification with compaction precipitation and
QIAamp Circulating Nucleic Acid Kit. The results showed that
the QIAamp kit was less than 1 cycle more sensitive than our
method at 10 ng/ml spiked DNA, and was 2–3 cycles more
sensitive at lower concentrations. In an effort to demonstrate the
general applicability of the method, the naturally present beta-
globin gene was also amplified from blood samples purified by
various means. Using the QIAamp Kit, the beta-globin gene was
detected at Ct values of 27.260.2, with spermine it was detected at
Ct values of 28.160.4, and with quatroquat at Ct values of
28.060.2. Thus, the QIAamp kit was only about one cycle more
effective than our compaction precipitation method.
These results were encouraging, since our method is new and
not fully optimized. The QIAamp kit employs a large amount of
carrier RNA (greater than 1 mg/ml) to enhance recovery, though
exogenous RNA would be undesirable in some downstream
applications. The addition of carrier RNA to our method did not
improve the recovery yield. The cost per sample for the QIAamp
kit is hundreds of times higher than compaction precipitation,
making our method an attractive choice for high throughput
application.
In summary, compaction precipitation proved to be a highly
effective method for the isolation and concentration of small DNA
fragments from serum. In our final protocol, the combination of
heat treatment with one round of compaction precipitation using
either spermine or quatroquat improved the sensitivity, especially
in samples with initial DNA concentrations between 1–10 ng/ml,
the typical concentration range for small DNAs in human blood
[21]. Compaction precipitation improved detectability for that
concentration range by at least 23 cycles, which is 223 or 6 to 7
orders of magnitude better than heat treatment alone (Table 1).
The overall sensitivity of the PCR was also increased by more than
five orders of magnitude; specifically, we were able to recover and
detect 10 pg/ml of a small DNA fragment in serum. The yield of
this method is not subject to significant inter-specimen variation
and its initial performance is comparable to that of a widely-used
commercial product, at a fraction of the cost. Furthermore, the
method is fast, simple, applicable to larger or multiple samples,
and avoids the use of hazardous chemicals.
Author Contributions
Conceived and designed the experiments: BV KA US RW. Performed the
experiments: BV KA. Analyzed the data: BV KA US RW. Wrote the
paper: BV US RW.
References
1. Goebel G, Zitt M, Zitt M, Muller HM (2005) Circulating nucleic acids in plasma
or serum (CNAPS) as prognostic and predictive markers in patients with solid
neoplasias. Disease Markers 21: 105–120.
2. Tamkovich SN, Cherepanova AV, Bryzgunova OE, Kolesnikova EV,
Permyakova VI, et al. (2008) Deoxyribonuclease activity in biological fluids of
healthy donors and cancer patients. Bull Exp Biol Med 146: 89–91.
3. Gal S, Fidler C, Lo YM, Taylor M, Han C, et al. (2004) Quantitation of
circulating DNA in the serum of breast cancer patients by real-time PCR.
Br J Cancer 90: 1211–1215.
4. Sozzi G, Conte D, Leon M, Ciricione R, Roz L, et al. (2003) Quantification of
free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 21:
3902–3908.
5. Hahn S, Zhong XY, Holzgreve W (2001) Quantification of circulating DNA: in
the preparation lies the rub. Clin Chem 47: 1577–1578.
6. Lo YMD, Chan KCA, Sun H, Chen EZ, Jiang P, et al. (2010) Maternal Plasma
DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of
the Fetus. Science Translational Medicine 2: 61ra91.
7. Kirsch C, Weickmann S, Schmidt B, Fleischhacker M (2008) An improved
method for the isolation of free-circulating plasma DNA and cell-free DNA from
Table 1. Detection of small DNA in serum after compaction
precipitation.
DNA concentration
Treatments* 0.01 ng/ml 0.1 ng/ml 1 ng/ml 10 ng/ml
No Heat No additives ND ND ND ND
Sp 21.560.4 1861 16.560.7 1461
QQ 22.1460.01 1861 16.960.3 13.560.1
SP (twice) 18.960.1 16.060.2 12.860.5 7.7360.06
QQ (twice) 18.6160.08 16.060.1 11.860.1 8.5660.01
Heat Heat only ND ND 33.360.2 29.960.1
SP 18.760.1 15.760.6 11.660.2 7.860.6
QQ 18.660.1 14.660.2 10.3760.07 6.560.2
SP (twice) 19.560.3 16.160.1 12.2460.08 8.460.2
QQ (twice) 17.9260.05 14.060.3 10.160.2 6.560.1
*Unless otherwise noted (‘twice’) all samples went through one round of the
compaction precipitation protocol. Heat: 10 min 95uC. SP: spermine (2 mM),
QQ: quatroquat (2 mM), ND: Not detectable.
doi:10.1371/journal.pone.0051863.t001
An Improved Method for the Isolation of Serum DNA
PLOS ONE | www.plosone.org 3 December 2012 | Volume 7 | Issue 12 | e51863
other body fluids. Circulating Nucleic Acids in Plasma and Serum V 1137: 135–
139.
8. Schmidt B, Weickmann S, Witt C, Fleischhacker M (2005) Improved method for
isolating cell-free DNA. Clinical Chemistry 51: 1561–1563.
9. Stroun M, Anker P, Lyautey J, Lederrey C, Maurice PA (1987) Isolation and
Characterization of DNA from the Plasma of Cancer-Patients. European
Journal of Cancer & Clinical Oncology 23: 707–712.
10. (2009) QIAampH Circulating Nucleic Acid Handbook.
11. (2010) Circulating DNA from Plasma. NucleoSpinH Plasma XS User Manual:
Macherey-Nagel.
12. Gosule LC, Schellman JA (1976) Compact Form of DNA Induced by
Spermidine. Nature 259: 333–335.
13. Anez-Lingerfelt M, Fox GE, Willson RC (2009) Reduction of DNA
contamination in RNA samples for reverse transcription-polymerase chain
reaction using selective precipitation by compaction agents. Analytical Bio-
chemistry 384: 79–85.
14. Hoopes BC, Mcclure WR (1981) Studies on the Selectivity of DNA Precipitation
by Spermine. Nucleic Acids Research 9: 5493–5504.
15. Mourich DV, Munks MW, Murphy JC, Willson RC, Hill AB (2003) Spermine
compaction is an efficient and economical method of producing vaccination-
grade DNA. Journal of Immunological Methods 274: 257–264.
16. Murphy JC, Wibbenmeyer JA, Fox GE, Willson RC (1999) Purification of
plasmid DNA using selective precipitation by compaction agents - A scaleable
method for the liquid-phase separation of plasmid DNA from RNA. Nature
Biotechnology 17: 822–823.
17. Razin S, Rozansky R (1959) Mechanism of the antibacterial action of spermine.
Archives of Biochemistry and Biophysics 81: 36–54.
18. Jung M, Klotzek S, Lewandowski M, Fleischhacker M, Jung K (2003) Changes
in concentration of DNA in serum and plasma during storage of blood samples.
Clinical Chemistry 49: 1028–1029.
19. Al-Soud WA, Jonsson LJ, Radstrom P (2000) Identification and characterization
of immunoglobulin G in blood as a major inhibitor of diagnostic PCR. Journal
of Clinical Microbiology 38: 345–350.
20. Al-Soud WA, Radstrom P (2001) Purification and characterization of PCR-
inhibitory components in blood cells. Journal of Clinical Microbiology 39: 485–
493.
21. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ (1977) Free DNA in the serum of
cancer patients and the effect of therapy. Cancer Res 37: 646–650.
An Improved Method for the Isolation of Serum DNA
PLOS ONE | www.plosone.org 4 December 2012 | Volume 7 | Issue 12 | e51863
